MRNA

NASDAQ 已收盘

Moderna

199.33 USD
▲+2.54+1.29%
盘后 198.06 -0.64%
2026-11-19
市值
$82.37B
市盈率
—
EPS
-7.03
股息率
—
52 周区间
22.28 – 280.80
成交量
8.20M
Beta
1.17
目标价
164.53
52W 低 22.2852W 高 280.80
价格走势

公司简介

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provid...

关联新闻